Search Browse Earnings

Anebulo Pharmaceuticals, Inc. — SlamSEC

Anebulo Pharmaceuticals, Inc.

Nasdaq:ANEB

Pharmaceutical Preparations·LAKEWAY, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

—

Net Income

-$8.2M

FY 2025

EPS (Diluted)

-$0.32

FY 2025

Stock Price

$0.36

-18.5%

2026-02-27

52W Range

$0.35 – $3.42

P/E Ratio

-1.1x

Market Cap

$14.7M

Cash

$3.1M

FY 2025

Total Debt

—

Net Cash

$3.1M

Enterprise Value

$11.6M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

CEO

Cunningham, Richard Anthony